Automated Immunoassay Analysers Market Size By Product (Immunofluorescence, Chemiluminescence, ELISA, Enzyme Linked Fluorescent System, Multiplexed Assay System, Radioimmunoassay), By Application (Infectious Diseases, Endocrinology, Drug Monitoring, Cardiology, Oncology, Allergy Testing), By End-use (Hospitals, Diagnostic Laboratories, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

Latest Update: Jan 2019 |  Published Date: Jun 2017 | 200 Pages | Report ID: GMI1727 | Authors: Sumant Ugalmugale Report Format: PDF

  Request Sample Inquiry Before Buying
Summary Table of Contents Industry Coverage Methodology Customize this Report

Industry Trends

Automated Immunoassay Analyzers Market size was valued over USD 9.1 billion in 2017 and is expected to witness more than 16.0% CAGR from 2018 to 2024.
 

U.S. automated immunoassay analyzers market, by product, 2017 & 2024 (USD Million)
U.S. automated immunoassay analyzers market, by product, 2017 & 2024 (USD Million)

Get more details on this report - Request Sample Pages
 

The automated immunoassay analyzers market is set to flourish owing to the growing shift in trend towards lab automated coupled with increasing prevalence of infectious diseases. These products are gaining popularity due to incremental innovation to the existing products and extended clinical applications. Hence, increase in applications of automated immunoassay analyzers will result in growing demand and adoption rate, fueling the market growth.
 

Recent trends of automation and integration has led to introduction of innovative products in the market, thus driving the market. Various pharmaceutical and biotechnology companies are increasingly using them for drug discovery purposes. Industry players are competing on the basis immunoassay system features, throughput, and menu expansion to capture business share by gaining access to hospitals and laboratories.
 

Lack of skilled professionals and labor force will be one of the major market impeding factor. The growing healthcare need across the globe hindered by the unavailability of required healthcare personals in the underdeveloped or developing regions. Also, stringent regulatory requirements and high cost involved in transitioning from conventional to automated instruments should hinder the industry growth.
 

Automated Immunoassay Analyzers Market, By Product

Germany automated immunoassay analyzers market share, by product, 2017
Germany automated immunoassay analyzers market share, by product, 2017

Get more details on this report - Request Sample Pages
 

Chemiluminescence immunoassay analyzers market held the largest revenue share in 2017 and was valued around USD 2,901.0 million. The largest share is attributed to increasing use due to its high sensitivity, and accuracy of analyte detection resulting in accurate diagnosis. The higher receptiveness and veracity of chemiluminescence immunoassay propels the growth prospects for the automated immunoassay analyzers market.
 

Automated enzyme-linked immunosorbent assay (ELISA) systems market is slated to witness robust growth at a CAGR of 15.9% over the projection period. It is expected to witness healthy growth owing to its extensive test menu at a relatively affordable cost. Moreover, mushrooming use of immunoassay tests in cancer, infectious disease testing, point-of-care in vitro diagnostics and therapeutic drug level monitoring are the factors accounting for upswing in the ELISA segment.
 

Automated Immunoassay Analyzers Market, By Application

Infectious diseases held the largest automated immunoassay analyzers market share in 2017 and was valued around USD 2,688.8 million. Increasing incidence of infectious diseases in the developing countries fueled business growth. For instance, pneumonia causes 1 in 5 deaths in children below five years of age globally, estimating to nearly 2 million deaths every year. Hence, growing number of people suffering from infectious diseases will result in increase in demand and adoption rate of automated immunoassay analyzers, boosting the market growth.
 

Cardiology is estimated to witness robust growth at a CAGR of 17.6% over the forecast years owing to the adoption of in cardiac marker testing for prevention of cardiovascular diseases. Rising incidence of cardiovascular disorders and increasing demand for minimally invasive treatment procedures should fuel industry growth. Soaring adolescent populations which are at elevated risk of growth of endocrine gland as a result of imbalance in hormones and spiraling prevalence of diabetes are the paramount factors impelling to drive the business growth.
 

Automated Immunoassay Analyzers Market, By End-user

Use of automated immunoassay analyzers in hospitals accounted for the largest revenue of USD 3,125.1 million in the year 2017. The high share of hospital was due to consolidation trend among hospitals leading to high test volumes, and favorable health reforms to provide better hospital care. Moreover, increasing number of corporate hospital chains should also boost automated immunoassay analyzers market demand over the forecast years. Diagnostic laboratories should witness highest growth over the forecast years, owing to the rising number of diagnostic laboratories. The use of automated systems helps laboratories to use their skilled resources for more important activities such as analysis and test results review.
 

Use of automated immunoassay analyzers in diagnostic laboratories is estimated to show considerable amount of growth at a CAGR of 16.6% over the forecast time period.  The use of automated systems helps laboratories to use their skilled resources for more important activities such as analysis and test results review. Apart from this, large corporate diagnostic laboratories are witnessing trend of expanding to remote areas by acquiring smaller diagnostic laboratories with minimal infrastructure. Hence, several applications of automated immunoassay analyzers will boost the business growth in the near future.
 

Automated Immunoassay Analyzers Market, By Region

Europe automated immunoassay analyzers market, by country, 2024 (USD Million)
Europe automated immunoassay analyzers market, by country, 2024 (USD Million)

Get more details on this report - Request Sample Pages
 

U.S. dominated the North America automated immunoassay analyzers market in the year 2017 and was valued around USD 3,206.5 million. The automation in laboratory significantly reduces the cost and time required for laboratory operations owing to that automated devices in laboratories are increasingly preferred in United States. Increasing adoption rates for lab automation technologies will have positive influence on the growth of U.S. automated immunoassay analyzers market in the forthcoming years.
 

China automated immunoassay analyzers market is estimated to witness significant growth at a CAGR of 18.8% during the projection period. Favorable government initiatives such as implementation of national project in 2008, aimed at improving the prevention and control of infectious diseases will influence China automated immunoassay analyzers market.
 

Competitive Market Share

Some of the notable automated immunoassay analyzers market participants include Abbott Diagnostics, Biokit, Biomerieux, Luminex Corporation, Roche Diagnostics, and Siemens Healthcare. The major strategy adopted by industry players include launching of technologically advanced innovative products. Industry participants are also focusing on product portfolio expansion to suit the requirements of different laboratory settings in terms of test volumes, assay menu, automation level and budget to stay ahead of the competition.
 

Automated Immunoassay Analyzers Industry Background
Automated Immunoassay Analyzers Market Segmentation

Get more details on this report - Request Sample Pages
 

Automated immunoassay analyzers are widely used in clinical laboratories and hospitals to perform biochemical tests aimed at detection and estimation of concentration of substance in the samples. The automated immunoassay analyzers market faces challenges in terms of cost associated in shifting from conventional lab products to automated ones. Small scale laboratories do not quickly adopt to change in instrumentation due to factors such as system revaluation, staff training, standardization of protocol and long purchase processes. However, manufacturers are seeking to introduce budget friendly analyzer systems or offering replacement benefits to generate revenue. The increased focus on multiplex technologies that use peptide and protein arrays by the companies to introduce multi parametric assays systems should further help manufacturers to boost their revenue share.

 


What Information does this report contain?

Historical data coverage: 2013 to 2017; Growth Projections: 2018 to 2024.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.


Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify

Connect with our sales team

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree